Alternative activation of macrophages in human peritoneum: implications for peritoneal fibrosis.

BACKGROUND Depending on the cytokine microenvironment, macrophages (Mϕ) can adopt a proinflammatory (M1) or a profibrotic (M2) phenotype characterized by the expression of cell surface proteins such as CD206 and CD163 and soluble factors such as CC chemokine ligand 18 (CCL18). A key role for Mϕ in fibrosis has been observed in diverse organ settings. We studied the Mϕ population in a human model of peritoneal dialysis in which continuous stress due to dialysis fluids and recurrent peritonitis represent a risk for peritoneal membrane dysfunction reflected as ultrafiltration failure (UFF) and peritoneal fibrosis. METHODS We used flow cytometry and quantitative reverse transcription-polymerase chain reaction to analyse the phenotype of peritoneal effluent Mϕ and tested their ability to stimulate the proliferation of human fibroblasts. Mϕ from non-infected patients were compared with those from patients with active peritonitis. Cytokine production was evaluated by enzyme-linked immunosorbent assay (ELISA) in spent dialysates and cell culture supernatants. RESULTS CD206(+) and CD163(+) M2 were found within peritoneal effluents by flow cytometry analysis, with increased frequencies of CD163(+) cells during peritonitis (P = 0.003). TGFB1, MMP9 and CCL18 messenger RNA (mRNA) levels in peritoneal macrophages (pMϕ) were similar to those found in M2 cells differentiated in vitro. The ability of pMϕ to stimulate fibroblast proliferation correlated with CCL18 mRNA levels (r = 0.924, P = 0.016). CCL18 production by pMϕ was confirmed by immunostaining of cytospin samples and ELISA. Moreover, CCL18 effluent concentrations correlated with decreased peritoneal function, which was evaluated as dialysate to plasma ratio of creatinine (r = 0.724, P < 0.0001), and were significantly higher in patients with UFF (P = 0.0025) and in those who later developed sclerosing peritonitis (P = 0.024). CONCLUSIONS M2 may participate in human peritoneal fibrosis through the stimulation of fibroblast cell growth and CCL18 production as high concentrations of CCL18 are associated with functional deficiency and fibrosis of the peritoneal membrane.

[1]  E. Brown,et al.  CCL18 in peritoneal dialysis patients and encapsulating peritoneal sclerosis , 2010, European journal of clinical investigation.

[2]  M. Olschewski,et al.  Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis. , 2009, American journal of respiratory and critical care medicine.

[3]  J. Edwards,et al.  Exploring the full spectrum of macrophage activation , 2008, Nature Reviews Immunology.

[4]  M. Lam,et al.  Regulation of CCN2/CTGF and related cytokines in cultured peritoneal cells under conditions simulating peritoneal dialysis. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[5]  R. Geffers,et al.  Gene Expression Profiling of Human Decidual Macrophages: Evidence for Immunosuppressive Phenotype , 2008, PloS one.

[6]  S. John,et al.  CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages , 2007, Proceedings of the National Academy of Sciences.

[7]  M. Röllinghoff,et al.  Expression and regulation of CCL18 in synovial fluid neutrophils of patients with rheumatoid arthritis , 2007, Arthritis research & therapy.

[8]  J. Jimenez-Heffernan,et al.  Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. , 2007, Journal of the American Society of Nephrology : JASN.

[9]  T. K. van den Berg,et al.  Human peritoneal macrophages show functional characteristics of M‐CSF‐driven anti‐inflammatory type 2 macrophages , 2007, European journal of immunology.

[10]  A. Prasse,et al.  CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis. , 2007, Arthritis and rheumatism.

[11]  A. Sica,et al.  New vistas on macrophage differentiation and activation , 2007, European journal of immunology.

[12]  M. Garcia-Blanco,et al.  Human Transcription Elongation Factor CA150 Localizes to Splicing Factor-Rich Nuclear Speckles and Assembles Transcription and Splicing Components into Complexes through Its Amino and Carboxyl Regions , 2006, Molecular and Cellular Biology.

[13]  Antje Prasse,et al.  A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. , 2006, American journal of respiratory and critical care medicine.

[14]  So-Jung Gwak,et al.  Skin regeneration using keratinocytes and dermal fibroblasts cultured on biodegradable microspherical polymer scaffolds. , 2005, Journal of biomedical materials research. Part B, Applied biomaterials.

[15]  J. Van Damme,et al.  Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes , 2005, Journal of leukocyte biology.

[16]  J. Suttles,et al.  Macrophages Sequentially Change Their Functional Phenotype in Response to Changes in Microenvironmental Influences1 , 2005, The Journal of Immunology.

[17]  S. Forbes,et al.  Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. , 2005, The Journal of clinical investigation.

[18]  T. Bellón,et al.  Recruitment of C-terminal Src kinase by the leukocyte inhibitory receptor CD85j. , 2004, Biochemical and biophysical research communications.

[19]  T. Wynn Fibrotic disease and the TH1/TH2 paradigm , 2004, Nature Reviews Immunology.

[20]  N. Longo,et al.  Regulated Expression of the Pathogen Receptor Dendritic Cell-specific Intercellular Adhesion Molecule 3 (ICAM-3)-grabbing Nonintegrin in THP-1 Human Leukemic Cells, Monocytes, and Macrophages* , 2004, Journal of Biological Chemistry.

[21]  P. De Baetselier,et al.  Alternatively activated macrophages during parasite infections. , 2004, Trends in parasitology.

[22]  M. Miyazaki,et al.  CCL17 and IL-10 as Effectors That Enable Alternatively Activated Macrophages to Inhibit the Generation of Classically Activated Macrophages1 , 2004, The Journal of Immunology.

[23]  P. Bonniaud,et al.  Basic Mechanisms and Clinical Implications of Peritoneal Fibrosis , 2003, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[24]  A. Yang,et al.  Myofibroblastic conversion of mesothelial cells. , 2003, Kidney international.

[25]  T. Geijtenbeek,et al.  Unique appearance of proliferating antigen-presenting cells expressing DC-SIGN (CD209) in the decidua of early human pregnancy. , 2003, The American journal of pathology.

[26]  J. Jimenez-Heffernan,et al.  Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. , 2003, The New England journal of medicine.

[27]  P. Allavena,et al.  Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. , 2002, Trends in immunology.

[28]  D. Reen,et al.  Lipopolysaccharide Induces Rapid Production of IL-10 by Monocytes in the Presence of Apoptotic Neutrophils1 , 2002, The Journal of Immunology.

[29]  Robert Coffman,et al.  CCL18/DC‐CK‐1/PARC up‐regulation in hypersensitivity pneumonitis , 2001, Journal of leukocyte biology.

[30]  R. Homer,et al.  Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor β1 , 2001, The Journal of experimental medicine.

[31]  K. Nitta,et al.  Identification of T Helper Cell Subsets in Continuous Ambulatory Peritoneal Dialysis Patients , 2001, Nephron.

[32]  S. Goerdt,et al.  Alternatively Activated Macrophages Differentially Express Fibronectin and Its Splice Variants and the Extracellular Matrix Protein βIG‐H3 , 2001, Scandinavian journal of immunology.

[33]  Bengt Rippe,et al.  Evaluation and Management of Ultrafiltration Problems in Peritoneal Dialysis , 2000 .

[34]  B. Antus,et al.  Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. , 2000, Cellular immunology.

[35]  I. Stamenkovic,et al.  Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. , 2000, Genes & development.

[36]  B. Hylander,et al.  Increased Levels of Transforming Growth Factor β1 and Basic Fibroblast Growth Factor in Patients on CAPD: A Study During Non-Infected Steady State and Peritonitis , 1999, Inflammation.

[37]  S. Goerdt,et al.  Other functions, other genes: alternative activation of antigen-presenting cells. , 1999, Immunity.

[38]  P. Högger,et al.  Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoid-inducible member of the scavenger receptor cysteine-rich family (CD163). , 1998, Journal of immunology.

[39]  V. Fadok,et al.  Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. , 1998, The Journal of clinical investigation.

[40]  S. Goerdt,et al.  Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern. , 1998, Journal of immunology.

[41]  S. Goerdt,et al.  Differences in angiogenic potential of classically vs alternatively activated macrophages. , 1997, Immunobiology.

[42]  T. Mcclanahan,et al.  A dendritic-cell-derived C–C chemokine that preferentially attracts naive T cells , 1997, Nature.

[43]  J. Lindeman,et al.  Monoclonal antibodies against the human mannose receptor as a specific marker in flow cytometry and immunohistochemistry for macrophages , 1997, Journal of leukocyte biology.

[44]  B. Hylander,et al.  Interleukin-10, Interferon Gamma, Interleukin-2, and Soluble Interleukin-2 Receptor Alpha Detected during Peritonitis in the Dialysate and Serum of Patients on Continuous Ambulatory Peritoneal Dialysis , 1996, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[45]  S. Wahl,et al.  Transforming growth factor beta enhances integrin expression and type IV collagenase secretion in human monocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[46]  S Gordon,et al.  Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation , 1992, The Journal of experimental medicine.

[47]  R. Geha,et al.  Human recombinant interleukin 4 induces Fc epsilon R2/CD23 on normal human monocytes , 1988, The Journal of experimental medicine.

[48]  Alberto Mantovani,et al.  Macrophage activation and polarization. , 2008, Frontiers in bioscience : a journal and virtual library.

[49]  S. Gordon Alternative activation of macrophages , 2003, Nature Reviews Immunology.

[50]  R. Selgas,et al.  Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. , 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[51]  R. Krediet The peritoneal membrane in chronic peritoneal dialysis. , 1999, Kidney international.

[52]  R. Selgas,et al.  Functional longevity of the human peritoneum: how long is continuous peritoneal dialysis possible? Results of a prospective medium long-term study. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.